Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT04363099
  4. Details
NCT04363099 Clinical Trial

Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.

Covid-19 Clinical Trial

— COVID AMBU 60  

Official title:
Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04363099
Other study ID # 2020-A01059-30
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2020
Est. completion date December 31, 2020

Study information
Verified date April 2020
Source Maison de Sante Pluridisciplinaire de Creil
Contact Svetlane DIMI, M.D
Phone +33650002085
Email svetlane.dimi@sfr.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Since December 2019, a new agent, the coronavirus SARS-Cov-2, has spread from China to the rest of the world causing an international epidemic of respiratory diseases called COVID-19. Oise was one of the first clusters in France, with more than 4,000 confirmed cases. A significant proportion (80%) of patients with COVID-19 are ambulatory. However, few data are available for this particular population in France. Thus, few clear recommendations are available.

We propose to conduct a large cohort of observation of suspected or confirmed COVID-19 patients on an ambulatory basis in the Oise region. This observatory will make it possible to describe the epidemiological characteristics and initial management of COVID-19 patients and to identify early severity factors.

Recruitment information / eligibility
Status Recruiting
Enrollment 1000
Est. completion date December 31, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers
Gender All
Age group N/A to 99 Years
Eligibility Inclusion Criteria:

- patients with covid 19 symptoms

- patients who had a contact with a person PCR Covid 19+

Exclusion Criteria:

- none

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• observational
observational management of outpatients COVID 19

Locations
Country Name City State
France Msp de Creil Creil

Sponsors (1)
Lead Sponsor Collaborator
Maison de Sante Pluridisciplinaire de Creil

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary clinical description of covid 19 ambulatory cases. 3 months
Secondary Biological and radiological description of ambulatory cases 3 months
Secondary Prevalence of positive cases (PCR and/or serological positive) 3 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure